Australia markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
69.55+0.38 (+0.55%)
At close: 04:00PM EST
68.38 -1.17 (-1.68%)
After hours: 06:45PM EST
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2021
31/12/2020
31/12/2019
31/12/2018
Total revenue
45,155,000
37,417,000
26,617,000
24,384,000
22,090,000
Cost of revenue
14,116,000
12,437,000
5,299,000
4,921,000
4,936,000
Gross profit
31,039,000
24,980,000
21,318,000
19,463,000
17,154,000
Operating expenses
Research development
9,558,000
9,736,000
6,213,000
6,059,000
5,932,000
Selling general and administrative
14,767,000
15,585,000
11,896,000
10,723,000
10,362,000
Total operating expenses
28,289,000
25,114,000
17,624,000
16,463,000
15,644,000
Operating income or loss
2,750,000
-134,000
3,694,000
3,000,000
1,510,000
Interest expense
1,298,000
1,276,000
1,272,000
1,402,000
1,366,000
Income before tax
1,087,000
-265,000
3,916,000
1,548,000
1,993,000
Income tax expense
-958,000
-380,000
772,000
321,000
-57,000
Income from continuing operations
2,045,000
115,000
3,144,000
1,227,000
2,050,000
Net income
2,040,000
112,000
3,196,000
1,335,000
2,155,000
Net income available to common shareholders
2,040,000
112,000
3,196,000
1,335,000
2,155,000
Basic EPS
-
0.04
1.22
0.52
0.85
Diluted EPS
-
0.04
1.22
0.52
0.85
Basic average shares
-
2,836,000
2,624,000
2,602,000
2,534,000
Diluted average shares
-
2,854,000
2,626,000
2,602,000
2,534,000
EBITDA
-
7,541,000
8,337,000
6,712,000
7,112,000